|
|||||
|
|
A phase II study of bevacizumab with modified OPTIMOX1 as first-line therapy for metastatic colorectal cancer: the TCOG-GI 0802 study |
|
| Authors: | Norisuke Nakayama Atsushi Sato Soichi Tanaka Ken Shimada Kazuo Konishi Eisaku Sasaki Kenji Hibi Hiroko Ichikawa Yoshinori Kikuchi Toshikazu Sakuyama Takashi Sekikawa Kazuhiko Hayashi Haruhiro Nishina The Tokyo Cooperative Oncology Group Tokyo Japan |
| Affiliation: | 1. Department of Gastroenterology, Kanagawa Cancer Center Hospital, 2-3-2,Nakao, Asahi-ku, Yokohama City, 241-8515, Japan 2. Department of Medical Oncology, Hirosaki University Graduate School of Medicine, Hirosaki, 036-8562, Japan 3. Unit of Coloproctology, Matsuda Hospital, Hamamatsu, 432-8061, Japan 4. Department of Internal Medicine, Showa University Northern Yokohama Hospital, Yokohama, 224-8503, Japan 5. Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, 142-8666, Japan 6. Department of Chemotherapy, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, 113-8677, Japan 7. Department of Surgery, Showa University Fujigaoka Hospital, Yokohama, 227-8501, Japan 8. Division of Gastroenterology, Tokyo Rinkai Hospital, Tokyo, 134-0086, Japan 9. Department of Clinical Oncology, Toho University Graduate School of Medicine, Tokyo, 143-8541, Japan 10. Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, 105-8471, Japan 11. Department of Internal Medicine, Showa University Toyosu Hospital, Tokyo, 135-8577, Japan 12. Department of Chemotherapy and Palliative Care, Tokyo Women’s Medical University Hospital, Tokyo, 162-8666, Japan 13. Division of Surgery, Koto Hospital, Tokyo, 136-0072, Japan |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |